CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.56
−1.79%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.53
- Revenue estimate
- $520.0K
Latest reported
- Last report date
- Sep 30, 2026
- EPS actual
- -$1.89
- EPS estimate
- -$2.45
- Revenue actual
- $108.0K
- Revenue estimate
- $480.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -67.5%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 30, 2026 | -$2.45 | -$1.89 | Beat 22.86% | $108.0K |
| May 29, 2026 | -$0.24 | -$0.23 | Beat 3.12% | $73.0K |
| Mar 26, 2026 | -$0.30 | -$0.67 | Miss -125.06% | $60.0K |
| Nov 26, 2025 | $0.38 | -$0.27 | Miss -171.05% | — |
| Aug 20, 2025 | -$0.10 | -$0.28 | Miss -180.00% | — |
| May 28, 2025 | -$0.37 | -$0.13 | Beat 64.86% | $2.1M |
| Mar 26, 2025 | -$0.42 | -$0.34 | Beat 19.05% | $164.0K |
| Nov 27, 2024 | -$0.28 | -$0.38 | Miss -35.71% | — |
| Aug 20, 2024 | -$0.35 | -$0.37 | Miss -5.71% | $249.0K |
| Apr 4, 2024 | -$0.35 | -$0.42 | Miss -20.00% | $98.0K |
| Jan 25, 2024 | -$0.07 | -$0.24 | Miss -242.86% | $299.0K |
| Nov 29, 2023 | -$0.13 | -$0.38 | Miss -192.31% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026